The growth of scions and rootstocks of compatible (Prunus persica L. Batsch cv. Springtime/Prunus cerasifera L. Ehrh. cv. myrobolan P2032) and incompatible (Prunus persica L. Batsch cv. Springtime/Prunus cerasifera L. Ehrh. cv. myrobolan P18) peach/plum grafts were compared. The composition of soluble carbohydrates in phloem and cortical tissues of both peach/plum grafts and ungrafted plums and the translocation of these compounds across the union of grafted plants were examined. Sorbitol and sucrose were the dominant sugars in the phloem and cortical tissues of plum. A cyanogenic glycoside, prunasin, was present in peach tissues in amounts equivalent to those of sorbitol or sucrose, whereas only small amounts of prunasin were detected in plum tissues. The concentration of prunasin was significantly higher in the phloem of the P18 rootstock of the incompatible graft. Sorbitol was the only sugar significantly depleted in rootstock tissues of the incompatible graft when the first foliar symptoms of graft incompatibility became evident. Translocation studies with 1-(14)C-deoxyglucose showed that the relative distribution of radioactivity across the graft union was similar in both compatible and incompatible grafts. However, the total amount of radioactivity translocated across the incompatible graft was less than one-third of that translocated across the compatible graft. The results are consistent with the hypothesis of a progressive poisoning of the root system in the incompatible graft by a compound synthesized in peach foliage. The role of prunasin as a possible candidate is discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/treephys/3.4.345 | DOI Listing |
Clin J Am Soc Nephrol
January 2025
Erasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Background: KEPs (kidney exchange programs) facilitate living donor kidney transplantations (LDKT) for patients with incompatible donors, who are typically higher risk than non-KEP patients because of higher sensitization and longer dialysis vintage. We conducted a comparative analysis of graft outcomes and risk factors for both KEP and non-KEP living donor kidney transplants.
Methods: All LDKTs performed in the Netherlands between 2004-2021 were included.
Transpl Int
January 2025
Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased risk of antibody-mediated rejection (AMR). Desensitization using imlifidase, which is more rapid and removes total body immunoglobulin G (IgG) to a greater extent than other methods, enables transplantation to occur between HLA-incompatible (HLAi) donor-recipient pairs and allows patients to have greater access to KTx. However, when the project was launched there was limited data and clinical experience with desensitization in general and with imlifidase specifically.
View Article and Find Full Text PDFJ Chin Med Assoc
January 2025
Division of Transplantation Surgery, Department of Surgery, Taipei Veterans General Hospital, Taiwan, ROC.
Background: ABO-incompatible liver transplantation (ABOi LT) can now be successfully performed with standard pretransplant induction therapy. For patients with chronic end-stage liver disease (ESLD), ABOi LT can achieve long-term outcomes comparable to those of blood type-compatible (ABOc) LT. Outcomes of patients with acute liver failure (ALF) who undergo urgent transplantation surgery with a limited induction period should be further investigated.
View Article and Find Full Text PDFAsian J Transfus Sci
October 2024
Department of Transfusion Medicine, Sri Balaji Action Medical Institute, New Delhi, India.
Background: High titers of anti-A and anti-B are considered to be one reason for hemolytic transfusion reactions and ABO hemolytic disease in fetus and neonates. There is no consensus for critical ABO antibody titers to guide transfusion or transplant decisions. Implementation of ABO titer measurement can favor reduction in transfusion reactions in nongroup "O" recipients.
View Article and Find Full Text PDFClin Exp Nephrol
January 2025
Division of Urology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Background: This study aimed to investigate the association between the Fc-gamma receptor IIIA (FCGR3A) 158 polymorphism and clinical outcomes in kidney transplantation (KTx) patients. Specifically, we focused on late-onset neutropenia (LON) in ABO-incompatible (ABOi) or HLA-incompatible (HLAi) KTx recipients who underwent rituximab (RTx) desensitization therapy.
Methods: FCGR3A 158F/V polymorphisms were identified in 85 ABOi or HLAi KTx recipients who underwent RTx desensitization at our institution between April 2008 and October 2021.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!